Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
CATALYST PHARMACEUTICALS INC
About CPRX
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing medicines for patients living with rare and difficult-to-treat diseases. The Company markets three drug products: FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone). FIRDAPSE is a treatment for people six years of age or older living with Lambert-Eaton myasthenic syndrome (LEMS). The Company, through its sub-licensee, also offers FIRDAPSE in Canada and Japan. FYCOMPA is a prescription medicine used alone or with other medicines to treat partial-onset seizures with or without secondarily generalized seizures in people with epilepsy aged four and older and with other medicines to treat primary generalized tonic-clonic seizures in people with epilepsy aged 12 and older. AGAMREE is a corticosteroid with a structure that retains the potent anti-inflammatory effects of traditional corticosteroids used in Duchenne muscular dystrophy.
Find out what a historical investment in CATALYST PHARMACEUTICALS INC would be worth today using our CPRX stock calculator.
Market Capitalisation
$3.82B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
2.36M
High today
$31.26
Low today
$31.21
Open price
$31.21
52-week high
$32.56
52-week low
$19.05
Ready to start your investing journey with Stake?
Open an accountHow do I buy CPRX shares in Australia?
Buying CPRX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in CATALYST PHARMACEUTICALS INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CPRX
What is the ticker symbol of CATALYST PHARMACEUTICALS INC?
The ticker symbol for CATALYST PHARMACEUTICALS INC is CPRX.
How much is one share of CPRX?
One share of CPRX is valued at $31.24 as of 20 May 2026.
What is the market capitalisation of CATALYST PHARMACEUTICALS INC CPRX?
As of 20 May 2026 CATALYST PHARMACEUTICALS INC has a market cap of $3.82B.
What is the P/E ratio of CPRX?
The Price to Earnings ratio of CPRX is 17.94.
What is the Earnings Per Share of CPRX?
The Earnings Per Share of CPRX is $1.74.
What is the 52-week high for CATALYST PHARMACEUTICALS INC stock?
The CATALYST PHARMACEUTICALS INC 52-week high stock price is $32.56.
What is the 52-week low for CATALYST PHARMACEUTICALS INC stock?
The CATALYST PHARMACEUTICALS INC 52-week low stock price is $19.05.
Can I buy CPRX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CPRX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CPRX on Stake
- Buy CPRX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of CPRX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
CPRX related stocks